Published in J Dent Res Dent Clin Dent Prospects on September 16, 2015
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst (1998) 5.05
Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol (1966) 3.89
Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol (2008) 2.93
The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther (1999) 2.89
Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): a case-control study. J Oral Pathol Med (1998) 1.54
Oral submucous fibrosis in India: a new epidemic? Natl Med J India (1998) 1.49
Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumour Biol (2000) 1.31
Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer. Br J Cancer (2000) 1.15
Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal (2014) 1.10
ERBB receptors in developing, dysplastic and malignant oral epithelia. Oral Oncol (2007) 1.08
Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res (2006) 1.05
Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma. Int J Oral Maxillofac Surg (2006) 0.99
Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas. Oral Oncol (2007) 0.97
HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (1995) 0.95
Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions. Oral Oncol (2001) 0.95
Expression of c-erbB-2 gene in human head and neck carcinoma. Anticancer Res (1993) 0.87
Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. Br J Cancer (2013) 0.86
Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study. Oral Oncol (2001) 0.86
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer. Anticancer Res (2000) 0.85
Clinical significance of epidermal growth factor receptor content in gastric cancer. Int J Biol Markers (2001) 0.83
Upregulation of epidermal growth factor receptor 4 in oral leukoplakia. Int J Oral Sci (2013) 0.83
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer (2008) 0.79
Evaluation of HER-2/neu (c-erbB-2) oncogene expression in whole organ sections of supraglottic squamous cell carcinoma. Ann Otol Rhinol Laryngol (1996) 0.78
The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia. Oncol Rep (2013) 0.77
Immunohistochemical expression of EGFR in oral leukoplakia: association with clinicopathological features and cellular proliferation. Med Oral Patol Oral Cir Bucal (2012) 0.77